Leveraging the United States Epicenter to Provide Insights on COVID-19 in Patients With Systemic Lupus Erythematosus.

There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

Abstract

To characterize patients with systemic lupus erythematosus (SLE) affected by coronavirus disease 2019 (COVID-19) and to analyze associations of comorbidities and medications on infection outcomes.

Related collections

Author and article information

Journal

Journal ID (iso-abbrev): Arthritis Rheumatol

Title: Arthritis & rheumatology (Hoboken, N.J.)

Publisher: Wiley

ISSN (Electronic): 2326-5205

ISSN (Print): 2326-5191

Publication date (Electronic): December 2020

Volume: 72

Issue: 12

Affiliations

[1 ] New York University School of Medicine, New York, New York.

[2 ] Albert Einstein College of Medicine, New York, New York.

[3 ] Cornell University, Ithaca, New York.

Article

Mid ID: NIHMS1627818

DOI: 10.1002/art.41450

PMC ID: 7941257

PubMed ID: 32715660

SO-VID: c94519ac-a44b-49b3-a83b-eed263124522

History

Data availability:

Comments

Comment on this article

scite_

Cited by 35

See all cited by

- Version 1